357 related articles for article (PubMed ID: 33185730)
41. [Clinical characteristic and treatment of cytomegalovirus retinitis in 80 patients with acquired immunodeficiency syndrome].
Yang Y; Jiang R; He T; Lu H; Zhang R; Shen Y; Zheng Y; Liu L; Wang W
Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):197-202. PubMed ID: 24841816
[TBL] [Abstract][Full Text] [Related]
42. Oral valganciclovir in human immunodeficiency virus-positive patients suffering from cytomegalovirus retinitis at a tertiary care hospital in North India.
Markan A; Gupta N; Dogra M; Sharma A; Singh R
Indian J Ophthalmol; 2022 Jul; 70(7):2472-2475. PubMed ID: 35791137
[TBL] [Abstract][Full Text] [Related]
43. Successful treatment of cytomegalovirus retinitis with oral/intravitreal antivirals in HIV-negative patients with lymphoma.
Tasiopoulou A; Urzua CA; Lightman S
Eye (Lond); 2023 Jun; 37(9):1895-1903. PubMed ID: 36192634
[TBL] [Abstract][Full Text] [Related]
44. Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy.
Zhao Q; Li NN; Chen YX; Zhao XY
Front Cell Infect Microbiol; 2023; 13():1107237. PubMed ID: 37305416
[TBL] [Abstract][Full Text] [Related]
45. Cytomegalovirus retinitis and AIDS in Edinburgh.
Dhillon B; Maclean H; Eddyshaw D; Cheong I; Flegg P; Brettle R
Int J STD AIDS; 1993; 4(6):339-41. PubMed ID: 8305575
[TBL] [Abstract][Full Text] [Related]
46. Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient.
Okamoto T; Okada M; Mori A; Saheki K; Takatsuka H; Wada H; Tamura A; Fujimori Y; Takemoto Y; Kanamaru A; Kakishita E
Bone Marrow Transplant; 1997 Nov; 20(9):801-3. PubMed ID: 9384487
[TBL] [Abstract][Full Text] [Related]
47. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
Boeckh M; Gallez-Hawkins GM; Myerson D; Zaia JA; Bowden RA
Transplantation; 1997 Jul; 64(1):108-13. PubMed ID: 9233710
[TBL] [Abstract][Full Text] [Related]
48. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
Reusser P; Hostettler B; Attehbofer R
Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510
[TBL] [Abstract][Full Text] [Related]
49. Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis.
Fan JJ; Tao Y; Hwang DK
Int J Ophthalmol; 2018; 11(10):1638-1642. PubMed ID: 30364196
[TBL] [Abstract][Full Text] [Related]
50. Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial.
Singh N; Paterson DL; Gayowski T; Wagener MM; Marino IR
Transplantation; 2000 Sep; 70(5):717-22. PubMed ID: 11003347
[TBL] [Abstract][Full Text] [Related]
51. Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant.
Kuo IC; Imai Y; Shum C; Martin DF; Kuppermann BD; Margolis TP
Am J Ophthalmol; 2003 Jan; 135(1):20-5. PubMed ID: 12504692
[TBL] [Abstract][Full Text] [Related]
52. Timing of antiretroviral therapy for HIV-infected patients with cytomegalovirus retinitis: study protocol of a multi-center prospective randomized controlled trial.
He XQ; Huang YQ; Zeng YM; Qin YY; Tang SQ; Xu XL; Harypursat V; Lu YQ; Liu M; Yuan J; Chen YK
Trials; 2021 Mar; 22(1):218. PubMed ID: 33736696
[TBL] [Abstract][Full Text] [Related]
53. Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients.
Qian Z; Li H; Tao Y; Li W
BMC Ophthalmol; 2018 Dec; 18(1):314. PubMed ID: 30526535
[TBL] [Abstract][Full Text] [Related]
54. Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications.
Jeon S; Lee WK
Ocul Immunol Inflamm; 2015; 23(5):392-9. PubMed ID: 25760914
[TBL] [Abstract][Full Text] [Related]
55. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
56. Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.
Laurenti L; Piccioni P; Cattani P; Cingolani A; Efremov D; Chiusolo P; Tarnani M; Fadda G; Sica S; Leone G
Haematologica; 2004 Oct; 89(10):1248-52. PubMed ID: 15477211
[TBL] [Abstract][Full Text] [Related]
57. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
[TBL] [Abstract][Full Text] [Related]
58. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
Vrabec TR; Baldassano VF; Whitcup SM
Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
[TBL] [Abstract][Full Text] [Related]
59. Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis.
Jacobson MA; Maecker HT; Orr PL; D'Amico R; Van Natta M; Li XD; Pollard RB; Bredt BM;
J Infect Dis; 2004 Apr; 189(8):1362-73. PubMed ID: 15073672
[TBL] [Abstract][Full Text] [Related]
60. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
